Summary
The fusion of postmitotic mononucleated myoblasts to form syncytial myofibers is a critical step in the formation of skeletal muscle. Myoblast fusion occurs both during development and throughout adulthood, as skeletal muscle growth and regeneration require the accumulation of additional nuclei within myofibers. Myoblasts must undergo a complex series of molecular and morphological changes prior to fusing with one another. Although many molecules regulating myoblast fusion have been identified, the precise mechanism by which these molecules act in concert to control fusion remains to be elucidated. A comprehensive understanding of how myo-blast fusion is controlled may contribute to the treatment of various disorders associated with loss of muscle mass. In this chapter, we examine progress made toward elucidating the cellular and molecular pathways involved in mammalian myoblast fusion. Special emphasis is placed on the molecules that regulate myofiber formation without discernibly affecting biochemical differentiation.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Andres, V. and Walsh, K. (1996) Myogenin expression, cell cycle withdrawal, and phenotypic differentiation are temporally separable events that precede cell fusion upon myogenesis. J. Cell Biol. 132(4), 657–566.
Capers, C. R. (1960) Multinucleation of skeletal muscle in vitro. J. Biophys. Biochem. Cytol. 7, 559–566.
Konigsberg, I. R. (1961) Some aspects of myogenesis in vitro. Circulation 24, 447–457.
Konigsberg, I. R., McElvain, N., Tootle, M., and Herrmann, H. (1960) The dissociability of deoxyribonucleic acid synthesis from the development of multinuclearity of muscle cells in culture. J. Biophys. Biochem. Cytol. 8, 333–343.
Stockdale, F. E. and Holtzer, H. (1961) DNA synthesis and myogenesis. Exp. Cell Res. 24, 508–520.
Menon, S. D. and Chia, W. (2001) Drosophila rolling pebbles: a multidomain protein required for myoblast fusion that recruits D-titin in response to the myoblast attractant Dumbfounded. Dev. Cell 1(5), 691–703.
Rau, A., Buttgereit, D., Holz, A., et al. (2001) rolling pebbles (rols) is required in Drosophila muscle precursors for recruitment of myoblasts for fusion. Development 128(24), 5061–5073.
Powell, J. A. (1973) Development of normal and genetically dystrophic mouse muscle in tissue culture. I. Prefusion and fusion activities of muscle cells: phase contrast and time lapse study. Exp. Cell Res. 80(2), 251–264.
Chazaud, B., Christov, C., Gherardi, R. K., and Barlovatz-Meimon, G. (1998) In vitro evaluation of human muscle satellite cell migration prior to fusion into myo-tubes. J. Muscle Res. Cell Motil. 19(8), 931–936.
Knudsen, K. A. and Horwitz, A. F. (1977) Tandem events in myoblast fusion. Dev. Biol. 58(2), 328–338.
Wakelam, M. J. (1985) The fusion of myoblasts. Biochem. J. 228(1), 1–12.
Kalderon, N. and Gilula, N. B. (1979) Membrane events involved in myoblast fusion. J. Cell Biol. 81(2), 411–425.
Robertson, T. A., Grounds, M. D., Mitchell, C. A., and Papadimitriou, J. M. (1990) Fusion between myogenic cells in vivo: an ultrastructural study in regenerating murine skeletal muscle. J. Struct. Biol. 105(1–3), 170–182.
Fulton, A. B., Prives, J., Farmer, S. R., and Penman, S. (1981) Developmental reorganization of the skeletal framework and its surface lamina in fusing muscle cells. J. Cell Biol. 91(1), 103–112.
Zhang, M. and McLennan, I. S. (1995) During secondary myotube formation, primary myotubes preferentially absorb new nuclei at their ends. Dev. Dyn. 204(2), 168–177.
Kitiyakara, A. and Angevine, D. M. (1963) Further studies on regeneration and growth in length of striated voluntary muscle with isotopes P32 and thymidine-H3. Nippon Byori Gakkai Kaishi 52, 180–183.
Aziz, U. and Goldspink, G. (1974) Distribution of mitotic nuclei in the biceps brachii of the mouse during post-natal growth. Anat. Rec. 179(1), 115–118.
Zeschnigk, M., Kozian, D., Kuch, C., Schmoll, M., and Starzinski-Powitz, A. (1995) Involvement of M-cadherin in terminal differentiation of skeletal muscle cells. J. Cell Sci. 108(Pt 9), 2973–2981.
Mege, R. M., Goudou, D., Diaz, C., et al. (1992) N-cadherin and N-CAM in myo-blast fusion: compared localisation and effect of blockade by peptides and antibodies. J. Cell Sci. 103(Pt 4), 897–906.
Charrasse, S., Comunale, F., Grumbach, Y., Poulat, F., Blangy, A., and Gauthier-Rouviere, C. (2006) RhoA GTPase regulates M-cadherin activity and myoblast fusion. Mol. Biol. Cell 17(2), 749–759.
Charrasse, S., Comunale, F., Fortier, M., Portales-Casamar, E., Debant, A., and Gauthier-Rouviere. C. (2007) M-cadherin activates Rac1 GTPase through the Rho-GEF trio during myoblast fusion. Mol. Biol. Cell 18(5), 1734 –1743.
Hollnagel, A., Grund, C., Franke, W. W., and Arnold, H. H. (2002) The cell adhesion molecule M-cadherin is not essential for muscle development and regeneration. Mol. Cell. Biol. 22(13), 4760–4770.
Knudsen, K. A., McElwee, S. A., and Myers, L. (1990) A role for the neural cell adhesion molecule, NCAM, in myoblast interaction during myogenesis. Dev. Biol. 138(1), 159–168.
Dickson, G., Peck, D., Moore, S. E., Barton, C.H., and Walsh, F. S. (1990) Enhanced myogenesis in NCAM-transfected mouse myoblasts. Nature 344(6264), 348–351.
Charlton, C. A., Mohler, W. A., and Blau, H. M. (2000) Neural cell adhesion molecule (NCAM) and myoblast fusion. Dev. Biol. 221(1), 112–119.
Menko, A. S. and Boettiger, D. (1987) Occupation of the extracellular matrix receptor, integrin, is a control point for myogenic differentiation. Cell 51(1), 51–57.
Schwander, M., Leu, M., and Stumm, M., et al. (2003) Beta1 integrins regulate myoblast fusion and sarcomere assembly. Dev. Cell. 4(5), 673–685.
Rosen, G. D., Sanes, J. R., LaChance, R., Cunningham, J. M., Roman, J., and Dean, D. C. (1992) Roles for the integrin VLA-4 and its counter receptor VCAM-1 in myogenesis. Cell 69(7), 1107–1119.
Yang, J. T., Rando, T. A., Mohler, W. A., Rayburn, H., Blau, H. M., and Hynes, R. O. (1996) Genetic analysis of alpha 4 integrin functions in the development of mouse skeletal muscle. J. Cell Biol. 135(3), 829–835.
Tachibana, I. and Hemler, M. E. (1999) Role of transmembrane 4 superfamily (TM4SF) proteins CD9 and CD81 in muscle cell fusion and myotube maintenance. J. Cell Biol. 146(4), 893–904.
Kaji, K., Oda, S., Miyazaki, S., and Kudo, A. (2002) Infertility of CD9-deficient mouse eggs is reversed by mouse CD9, human CD9, or mouse CD81; polyadenylated mRNA injection developed for molecular analysis of sperm–egg fusion. Dev. Biol. 247(2), 327–334.
Takeda, Y., Tachibana, I., Miyado, K., et al. (2003) Tetraspanins CD9 and CD81 function to prevent the fusion of mononuclear phagocytes. J. Cell Biol. 161(5), 945–956.
Rubinstein, E., Ziyyat, A., Prenant, M., et al. (2006) Reduced fertility of female mice lacking CD81. Dev. Biol. 290(2), 351–358.
Seebacher, T., Manske, M., Zoller, J., Crabb, J., and Bade, E. G. (1992) The EGF-inducible protein EIP-1 of migrating normal and malignant rat liver epithelial cells is identical to plasminogen activator inhibitor 1 and is a component of the ECM migration tracks. Exp. Cell Res. 203(2), 504–507.
Wei, Y., Waltz, D. A., Rao, N., Drummond, R. J., Rosenberg, S., and Chapman, H. A. (1994) Identification of the urokinase receptor as an adhesion receptor for vitronectin. J. Biol. Chem. 269(51), 32380–32388.
Wang, N., Planus, E., Pouchelet, M., Fredberg, J. J., and Barlovatz-Meimon, G. (1995) Urokinase receptor mediates mechanical force transfer across the cell surface. Am. J. Physiol. 268(4 Pt 1), C1062–C1066.
Quax, P. H., Frisdal, E., Pedersen, N., et al. (1992) Modulation of activities and RNA level of the components of the plasminogen activation system during fusion of human myogenic satellite cells in vitro. Dev. Biol. 151(1), 166–175.
Bonavaud, S., Charriere-Bertrand, C., Rey, C., et al. (1997) Evidence of a non-conventional role for the urokinase tripartite complex (uPAR/uPA/PAI-1) in myogenic cell fusion. J. Cell Sci. 110(Pt 9), 1083–1089.
Chazaud, B., Bonavaud, S., Plonquet, A., Pouchelet, M., Gherardi, R. K., and Barlovatz-Meimon, G. (2000) Involvement of the [uPAR:uPA:PAI-1:LRP] complex in human myogenic cell motility. Exp. Cell Res. 258(2), 237–244.
Gorza, L. and Vitadello, M. (2000) Reduced amount of the glucose-regulated protein GRP94 in skeletal myoblasts results in loss of fusion competence. FASEB J. 14(3), 461–475.
Galbiati, F., Volonte, D., Engelman, J. A., Scherer, P. E., and Lisanti, M. P. (1999) Targeted down-regulation of caveolin-3 is sufficient to inhibit myotube formation in differentiating C2C12 myoblasts. Transient activation of p38 mitogen-activated protein kinase is required for induction of caveolin-3 expression and subsequent myotube formation. J. Biol. Chem. 274(42), 30315–30321.
Doherty, K. R., Cave, A., Davis, D. B., et al. (2005) Normal myoblast fusion requires myoferlin. Development 132(24), 5565–5575.
Entwistle, A., Zalin, R. J., Warner, A. E., and Bevan, S. (1988) A role for acetylcholine receptors in the fusion of chick myoblasts. J. Cell Biol. 106(5), 1703–1712.
Krause, R. M., Hamann, M., Bader, C. R., Liu, J. H., Baroffio, A., and Bernheim, L. (1995) Activation of nicotinic acetylcholine receptors increases the rate of fusion of cultured human myoblasts. J. Physiol. 489(Pt 3), 779–790.
Bois, P. R. and Grosveld, G. C. (2003) FKHR (FOXO1a) is required for myotube fusion of primary mouse myoblasts. EMBO J. 22(5), 1147–1157.
Nishiyama, T., Kii, I., and Kudo, A. (2004) Inactivation of Rho/ROCK signaling is crucial for the nuclear accumulation of FKHR and myoblast fusion. J. Biol. Chem. 279(45), 47311–47319.
Bois, P. R., Brochard, V. F., Salin-Cantegrel, A. V., Cleveland, J. L., and Grosveld, G. C. (2005) FoxO1a-cyclic GMP-dependent kinase I interactions orchestrate myo-blast fusion. Mol. Cell. Biol. 25(17), 7645–7656.
Furuyama, T., Kitayama, K., Shimoda, Y., et al. (2004) Abnormal angiogenesis in Foxo1 (Fkhr)-deficient mice. J. Biol. Chem. 279(33), 34741–34749.
Kamei, Y., Miura, S., Suzuki, M., et al. (2004) Skeletal muscle FOXO1 (FKHR) transgenic mice have less skeletal muscle mass, down-regulated Type I (slow twitch/red muscle) fiber genes, and impaired glycemic control. J. Biol. Chem. 279(39), 41114–41123.
Cuenda, A. and Cohen, P. (1999) Stress-activated protein kinase-2/p38 and a rapamycin-sensitive pathway are required for C2C12 myogenesis. J. Biol. Chem. 274(7), 4341–4346.
Park, I. H. and Chen, J. (2005) Mammalian target of rapamycin (mTOR) signaling is required for a late-stage fusion process during skeletal myotube maturation. J. Biol. Chem. 280(36), 32009–32017.
Glading, A., Bodnar, R. J., Reynolds, I. J., et al. (2004) Epidermal growth factor activates m-calpain (calpain II), at least in part, by extracellular signal-regulated kinase-mediated phosphorylation. Mol. Cell. Biol. 24(6), 2499–2512.
Richard, I., Broux, O., Allamand, V., et al. (1995) Mutations in the proteolytic enzyme calpain 3 cause limb-girdle muscular dystrophy type 2A. Cell 81(1), 27–40.
Elamrani, N., Brustis, J. J., Dourdin, N., et al. (1995) Desmin degradation and Ca(2+)-dependent proteolysis during myoblast fusion. Biol. Cell 85(2–3), 177–183.
Stockholm, D., Barbaud, C., Marchand, S., et al. (1999) Studies on calpain expression during differentiation of rat satellite cells in primary cultures in the presence of heparin or a mimic compound. Exp. Cell Res. 252(2), 392–400.
Joffroy, S., Dourdin, N., Delage, J. P., Cottin, P., Koenig, J., and Brustis, J. J. (2000) M-calpain levels increase during fusion of myoblasts in the mutant muscular dys-genesis (mdg) mouse. Int. J. Dev. Biol. 44(4), 421–428.
Kwak, K. B., Kambayashi, J., Kang, M. S., Ha, D. B., and Chung, C. H. (1993) Cell-penetrating inhibitors of calpain block both membrane fusion and filamin cleavage in chick embryonic myoblasts. FEBS Lett. 323(1–2), 151–154.
Ueda, Y., Wang, M. C., Ou, B. R., et al. (1998) Evidence for the participation of the proteasome and calpain in early phases of muscle cell differentiation. Int. J. Biochem. Cell Biol. 30(6), 679–694.
Barnoy, S., Maki, M., and Kosower, N. S. (2005) Overexpression of calpastatin inhibits L8 myoblast fusion. Biochem. Biophys. Res. Commun. 332(3), 697–701.
Temm-Grove, C. J., Wert, D., Thompson, V. F., Allen, R. E., and Goll, D. E. (1999) Microinjection of calpastatin inhibits fusion in myoblasts. Exp. Cell Res. 247(1), 293–303.
Dourdin, N., Brustis, J. J., Balcerzak, D., et al. (1997) Myoblast fusion requires fibronectin degradation by exteriorized M-calpain. Exp. Cell Res. 235(2), 385– 394.
Dourdin, N., Balcerzak, D., Brustis, J. J., Poussard, S., Cottin, P., and Ducastaing, A. (1999) Potential m-calpain substrates during myoblast fusion. Exp. Cell Res. 246(2), 433–442.
Dedieu, S., Poussard, S., Mazeres, G., et al. (2004) Myoblast migration is regulated by calpain through its involvement in cell attachment and cytoskeletal organization. Exp. Cell Res. 292(1), 187–200.
Kramerova, I., Kudryashova, E., Tidball, J. G., and Spencer, M. J. (2004) Null mutation of calpain 3 (p94) in mice causes abnormal sarcomere formation in vivo and in vitro. Hum. Mol. Genet. 13(13), 1373–1388.
Kramerova, I., Kudryashova, E., Wu, B., and Spencer, M. J. (2006) Regulation of M-cadherin–{beta}-catenin complex by calpain 3 during terminal stages of myogenic differentiation. Mol. Cell Biol. 26(22), 8437–8447.
Shafey, D., Cote, P. D., and Kothary, R. (2005) Hypomorphic Smn knockdown C2C12 myoblasts reveal intrinsic defects in myoblast fusion and myotube morphology. Exp. Cell Res. 311(1), 49–61.
Shainberg, A., Yagil, G., and Yaffe, D. (1969) Control of myogenesis in vitro by Ca 2+ concentration in nutritional medium. Exp. Cell Res. 58(1), 163–167.
Salzberg, S., Mandelboim, M., Zalcberg, M., Shainberg, A., and Mandelbaum, M. (1995) Interruption of myogenesis by transforming growth factor beta 1 or EGTA inhibits expression and activity of the myogenic-associated (2'–5') oligoadenylate synthetase and PKR. Exp. Cell Res. 219(1), 223–232.
Przybylski, R. J., Szigeti, V. , Davidheiser, S., and Kirby, A. C. (1994) Calcium regulation of skeletal myogenesis. II. Extracellular and cell surface effects. Cell Calcium 15(2), 132–142.
Constantin, B., Cognard, C., and Raymond, G. (1996) Myoblast fusion requires cytosolic calcium elevation but not activation of voltage-dependent calcium channels. Cell Calcium 19(5), 365–374.
David, J. D. and Higginbotham, C. A. (1981) Fusion of chick embryo skeletal myoblasts: interactions of prostaglandin E1, adenosine 3 :5 monophosphate, and calcium influx. Dev. Biol. 82(2), 308–316.
Przybylski, R. J., MacBride, R. G., and Kirby, A. C. (1989) Calcium regulation of skeletal myogenesis. I. Cell content critical to myotube formation. In Vitro Cell Dev. Biol. 25(9), 830–838.
Knudsen, K. A. (1985) The calcium-dependent myoblast adhesion that precedes cell fusion is mediated by glycoproteins. J. Cell Biol. 101(3), 891–897.
Knudsen, K. A., Myers, L., and McElwee, S. A. (1990) A role for the Ca2(+)-dependent adhesion molecule, N-cadherin, in myoblast interaction during myogenesis. Exp. Cell Res. 188(2), 175–184.
Papahadjopoulos, D., Nir, S., and Duzgunes, N. (1990) Molecular mechanisms of calcium-induced membrane fusion. J. Bioenerg. Biomembr. 22(2), 157–179.
Konig, S., Beguet, A., Bader, C. R., and Bernheim, L. (2006) The calcineurin pathway links hyperpolarization (Kir2.1)-induced Ca2+ signals to human myoblast differentiation and fusion. Development 133(16), 3107–3114.
Konig, S., Hinard, V., Arnaudeau, S., et al. (2004) Membrane hyperpolarization triggers myogenin and myocyte enhancer factor-2 expression during human myo-blast differentiation. J. Biol. Chem. 279(27), 28187–28196.
Friday, B. B., Horsley, V., and Pavlath, G. K. (2000) Calcineurin activity is required for the initiation of skeletal muscle differentiation. J. Cell Biol. 149(3), 657–666.
Friday, B. B., Mitchell, P. O., Kegley, K. M., and Pavlath, G. K. (2003) Calcineurin initiates skeletal muscle differentiation by activating MEF2 and MyoD. Differentiation 71(3), 217–227.
Xu, Q., Yu, L., Liu, L., et al. (2002) p38 Mitogen-activated protein kinase-, calcium-calmodulin-dependent protein kinase-, and calcineurin-mediated signaling pathways transcriptionally regulate myogenin expression. Mol. Biol. Cell 13(6), 1940–1952.
Choi, S. W., Baek, M. Y., and Kang, M. S. (1992) Involvement of cyclic GMP in the fusion of chick embryonic myoblasts in culture. Exp. Cell Res. 199(1), 129–133.
Pisconti, A., Brunelli, S., Di Padova, M., et al. (2006) Follistatin induction by nitric oxide through cyclic GMP: a tightly regulated signaling pathway that controls myoblast fusion. J. Cell Biol. 172(2), 233–244.
Lee, K. H., Baek, M. Y. , Moon, K. Y., et al. (1994) Nitric oxide as a messenger molecule for myoblast fusion. J. Biol. Chem. 269(20), 14371–14374.
Long, J. H., Lira, V. A., Soltow, Q. A., Betters, J. L., Sellman, J. E., and Criswell, D. S. (2006) Arginine supplementation induces myoblast fusion via augmentation of nitric oxide production. J. Muscle Res. Cell Motil. 27(8), 577–584.
Lee, S. J. and McPherron, A. C. (2001) Regulation of myostatin activity and muscle growth. Proc. Natl. Acad. Sci. U.S.A. 98(16), 9306–9311.
Iezzi, S., Di Padova, M., Serra, C., et al. (2004) Deacetylase inhibitors increase muscle cell size by promoting myoblast recruitment and fusion through induction of follistatin. Dev. Cell 6(5), 673–684.
Abbott, K. L., Friday, B. B., Thaloor, D., Murphy, T.J., and Pavlath, G. K. (1998) Activation and cellular localization of the cyclosporine A-sensitive transcription factor NF-AT in skeletal muscle cells. Mol. Biol. Cell 9(10), 2905–2916.
Jacquemin, V., Butler-Browne, G. S., Furling, D., and Mouly, V. (2007) IL-13 mediates the recruitment of reserve cells for fusion during IGF-1–induced hypertrophy of human myotubes. J. Cell Sci. 120(Pt 4), 670–681.
Pavlath, G. K. and Horsley, V. (2003) Cell fusion in skeletal muscle–central role of NFATC2 in regulating muscle cell size. Cell Cycle 2(5), 420–423.
Horsley, V., Friday, B. B., Matteson, S., Kegley, K. M., Gephart, J., and Pavlath, G. K. (2001) Regulation of the growth of multinucleated muscle cells by an NFATC2-dependent pathway. J. Cell Biol. 153(2), 329–338.
Horsley, V., Jansen, K. M., Mills, S. T., and Pavlath, G. K. (2003) IL-4 acts as a myoblast recruitment factor during mammalian muscle growth. Cell 113(4), 483–494.
Schulze, M., Belema-Bedada, F., Technau, A., and Braun, T. (2005) Mesenchymal stem cells are recruited to striated muscle by NFAT/IL-4–mediated cell fusion. Genes Dev. 19(15), 1787–1798.
Lafreniere, J. F., Mills, P., Bouchentouf, M., and Tremblay, J. P. (2006) Interleukin-4 improves the migration of human myogenic precursor cells in vitro and in vivo. Exp. Cell Res. 312(7), 1127–1141.
Jansen, K. M. and Pavlath, G. K. (2006) Mannose receptor regulates myoblast motility and muscle growth. J. Cell Biol. 174(3), 403–413.
Horsley, V. and Pavlath, G. K. (2003) Prostaglandin F2(alpha) stimulates growth of skeletal muscle cells via an NFATC2-dependent pathway. J. Cell Biol. 161(1), 111–118.
Sotiropoulos, A., Ohanna, M., Kedzia, C., et al. (2006) Growth hormone promotes skeletal muscle cell fusion independent of insulin-like growth factor 1 up-regulation. Proc. Natl. Acad. Sci. U.S.A. 103(19), 7315–7320.
Fornaro, M., Burch, P. M., Yang, W., et al. (2006) SHP-2 activates signaling of the nuclear factor of activated T cells to promote skeletal muscle growth. J. Cell Biol. 175(1), 87–97.
Ohtake, Y., Tojo, H., and Seiki, M. (2006) Multifunctional roles of MT1-MMP in myofiber formation and morphostatic maintenance of skeletal muscle. J. Cell Sci. 119(Pt 18), 3822–3832.
Entwistle, A., Curtis, D. H., and Zalin, R. J. (1986) Myoblast fusion is regulated by a prostanoid of the one series independently of a rise in cyclic AMP. J. Cell Biol. 103(3), 857–866.
Shen, W., Prisk, V., Li, Y., Foster, W., and Huard, J. (2006) Inhibited skeletal muscle healing in cyclooxygenase-2 gene-deficient mice: the role of PGE2 and PGF2alpha. J. Appl. Physiol. 101(4), 1215–1221.
Chen, E. H., Pryce, B. A., Tzeng, J. A., Gonzalez, G. A., and Olson, E. N. (2003) Control of myoblast fusion by a guanine nucleotide exchange factor, loner, and its effector ARF6. Cell 114(6), 751–762.
Kim, S., Shilagardi, K., Zhang, S., et al. (2007) A critical function for the actin cytoskeleton in targeted exocytosis of prefusion vesicles during myoblast fusion. Dev. Cell 12(4), 571–586.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2008 Humana Press, a part of Springer Science + Business Media, LLC
About this protocol
Cite this protocol
Jansen, K.M., Pavlath, G.K. (2008). Molecular Control of Mammalian Myoblast Fusion. In: Chen, E.H. (eds) Cell Fusion. Methods in Molecular Biology™, vol 475. Humana Press. https://doi.org/10.1007/978-1-59745-250-2_7
Download citation
DOI: https://doi.org/10.1007/978-1-59745-250-2_7
Publisher Name: Humana Press
Print ISBN: 978-1-58829-911-6
Online ISBN: 978-1-59745-250-2
eBook Packages: Springer Protocols